JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rennen, H. J.J.M.
Right arrow Articles by Corstens, F. H.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rennen, H. J.J.M.
Right arrow Articles by Corstens, F. H.M.
Journal of Nuclear Medicine Vol. 44 No. 9 1502-1509
© 2003 by Society of Nuclear Medicine


Basic Science Investigations

Kinetics of 99mTc-Labeled Interleukin-8 in Experimental Inflammation and Infection

Huub J.J.M. Rennen, MSc;, Otto C. Boerman, PhD;, Wim J.G. Oyen, MD, PhD; and Frans H.M. Corstens, MD

Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands

The cytokine interleukin-8 (IL-8) binds with high affinity to the CXCR1 and CXCR2 receptors on neutrophils. In previous studies, we showed that 99mTc-IL-8 could rapidly and effectively delineate foci of infection and inflammation in rabbit models of intramuscular infection, colitis, and osteomyelitis. Here, the in vivo kinetics and pharmacodynamics of 99mTc-IL-8 are studied in detail. A derivative of hydrazinonicotinamide (HYNIC) was used as a bifunctional coupling agent to label the protein with 99mTc. Methods: To address specificity of uptake of 99mTc-IL-8 in the abscess, uptake in turpentine-induced abscesses in neutropenic rabbits was compared with uptake in turpentine-induced abscesses in normal rabbits. The pharmacokinetics of 99mTc-IL-8 were studied in neutropenic rabbits and compared with those in normal rabbits. To investigate the interaction of 99mTc-IL-8 with blood cells in circulation in normal rabbits, the distribution of the radiolabel over circulating white and red blood cells and plasma was determined. The in vivo kinetics of 99mTc-IL-8 were studied by quantitative analysis of whole-body images acquired between 0 and 6 h after injection. The results of this analysis (in vivo biodistribution) were validated by ex vivo counting of radioactivity in dissected tissues. Results: The abscess uptake (percentage of injected dose per gram of tissue [%ID/g] ± SEM) in immunocompetent rabbits (0.41 ± 0.05) was 10 times higher than that in neutropenic rabbits (0.038 ± 0.014), demonstrating specificity of the target uptake of 99mTc-IL-8. Abscess-to-muscle ratios ± SEM were also 10 times higher (110 ± 10 vs. 10 ± 5). Lung and spleen uptake in normal rabbits was 3 times higher than that in neutropenic rabbits. The blood clearance of the radiolabel in neutropenic rabbits was similar to that in normal rabbits. In circulation, most of 99mTc-IL-8 (70%) was found in the plasma fraction. Less than one third was associated with red blood cells, and only a very low percentage (<2.5%) was associated with white blood cells. Image analysis revealed a gradually increasing abscess uptake over time up to >15%ID, which was confirmed by ex vivo {gamma}-counting of the infected muscle. The highest increase in uptake in the abscess was observed after 2 h following injection, when most of 99mTc-IL-8 was cleared from the blood, suggesting specific neutrophil-mediated accumulation of 99mTc-IL-8 in the abscess. Furthermore, region-of-interest analysis revealed that gradual accumulation of 99mTc-IL-8 in the abscess was accompanied by a simultaneous clearance of activity from the lungs, suggesting that neutrophil-associated 99mTc-IL-8 that was initially trapped in the lungs migrates to the abscess at later time points, favoring neutrophil-bound transportation from the lungs to the abscess. Conclusion: Substantial support is given for the hypothesis that 99mTc-IL-8 localizes in the abscess, mainly bound to peripheral neutrophils. Accumulation in the abscess is a highly specific, neutrophil-driven process. As assessed by in vivo and ex vivo analysis, the total fraction that accumulates in the inflamed tissue is extremely high (up to >15 %ID) compared with that of other agents used for imaging infection and inflammation.

Key Words: 99mTc-labeled interleukin-8 • kinetics • inflammation • infection




This article has been cited by other articles:


Home page
JNMHome page
C. P. Bleeker-Rovers, H. J.J.M. Rennen, O. C. Boerman, A. B. Wymenga, E. P. Visser, J. H. Bakker, J. W.M. van der Meer, F. H.M. Corstens, and W. J.G. Oyen
99mTc-Labeled Interleukin 8 for the Scintigraphic Detection of Infection and Inflammation: First Clinical Evaluation
J. Nucl. Med., March 1, 2007; 48(3): 337 - 343.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. Stefanovic, D. A. Brenner, and B. Stefanovic
Direct Hepatotoxic Effect of KC Chemokine in the Liver Without Infiltration of Neutrophils
Experimental Biology and Medicine, September 1, 2005; 230(8): 573 - 586.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. E.M. van Eerd, M. Broekema, T. D. Harris, D. S. Edwards, W. J.G. Oyen, F. H.M. Corstens, and O. C. Boerman
Imaging of Infection and Inflammation with an Improved 99mTc-Labeled LTB4 Antagonist
J. Nucl. Med., September 1, 2005; 46(9): 1546 - 1551.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. J. J. M. Rennen, C. P. Bleeker-Rovers, J. E. M. van Eerd, C. Frielink, W. J. G. Oyen, F. H. M. Corstens, and O. C. Boerman
99mTc-Labeled Interleukin-8 for Scintigraphic Detection of Pulmonary Infections
Chest, December 1, 2004; 126(6): 1954 - 1961.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Singer and P. J. Sansonetti
IL-8 Is a Key Chemokine Regulating Neutrophil Recruitment in a New Mouse Model of Shigella-Induced Colitis
J. Immunol., September 15, 2004; 173(6): 4197 - 4206.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.